Cargando…

Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes

OBJECTIVE: To evaluate the effect of insulin sensitizer on inflammatory cytokines and oxidative stress in patients with newly diagnosed type 2 diabetes mellitus (T2DM). METHODS: After intensive insulin therapy, patients with newly diagnosed T2DM were continuously treated with either insulin sensitiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juan, Shen, Xingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499940/ https://www.ncbi.nlm.nih.gov/pubmed/31073335 http://dx.doi.org/10.1186/s13098-019-0432-z

Ejemplares similares

The effect of short‐term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes
por: He, Junyu, et al.
Publicado: (2022)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

The effect of short-term intensive insulin therapy in newly-diagnosed Type-2 diabetic patients
por: Karacaer, Cengiz, et al.
Publicado: (2021)

Thresholds of Oxidative Stress in Newly Diagnosed Diabetic Patients on Intensive Glucose-Control Therapy
por: Kulkarni, Rashmi, et al.
Publicado: (2014)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats
por: Kavak, Servet, et al.
Publicado: (2012)

Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes
por: Zhang, Wei, et al.
Publicado: (2021)

Analysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes Patients
por: Wang, Zhen, et al.
Publicado: (2016)

Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
por: Chen, Harn-Shen, et al.
Publicado: (2008)

Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes
por: Zheng, Hai-Lan, et al.
Publicado: (2020)

Correction to: Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes
por: Zhang, Wei, et al.
Publicado: (2022)

Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes
por: Niu, Guifen, et al.
Publicado: (2016)

Leptin in Children with Newly Diagnosed Type 1 Diabetes: Effect of Insulin Therapy
por: McCormick, Kenneth L., et al.
Publicado: (2001)

Anasarca in Newly Diagnosed Type 1 Diabetes: Review of the Pathophysiology of Insulin Edema
por: Wong, Marc, et al.
Publicado: (2020)

Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease
por: LI, QING, et al.
Publicado: (2015)

SUN-681 Does Short Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Mellitus Delay Eventual Insulin Dependence
por: Patil, Madhuri, et al.
Publicado: (2020)

TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
por: Bonora, Enzo, et al.
Publicado: (2022)

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis
por: Lu, Yu, et al.
Publicado: (2015)

Oxidative stress and adipokine levels were significantly correlated in diabetic patients with hyperglycemic crises
por: Li, Juan, et al.
Publicado: (2019)

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
por: Ma, Jing, et al.
Publicado: (2016)

Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
por: Buschard, Karsten, et al.
Publicado: (2020)

Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes
por: Xu, Lijuan, et al.
Publicado: (2020)

Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes
por: Liu, Liehua, et al.
Publicado: (2023)

Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
por: Hao, Zirui, et al.
Publicado: (2022)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
por: Seghieri, Marta, et al.
Publicado: (2018)

Improving Clinician Confidence in Insulin Prescriptions at Discharge for Individuals With Newly Diagnosed Type 1 Diabetes
por: Shoaib, Haris, et al.
Publicado: (2023)

Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes
por: Alnek, Kristi, et al.
Publicado: (2015)

Depression in newly diagnosed type 2 diabetes
por: Yu, Ruan, et al.
Publicado: (2010)

Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea
por: Son, Jang Won, et al.
Publicado: (2015)

Influence of the Type of Basal Insulin and Other Variables on Clinical Outcomes in Children with Newly Diagnosed Type 1 Diabetes
por: Garrison, Ruth M., et al.
Publicado: (2014)

TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?
por: Lingvay, Ildiko, et al.
Publicado: (2009)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
por: Han, Eugene, et al.
Publicado: (2016)

Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wan, Heng, et al.
Publicado: (2016)

Newly Diagnosed Type 1 Diabetes in an Elderly Patient
por: Cosme, Inês, et al.
Publicado: (2023)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_erauatag4u2o4caf2i10snf6st